BioCardia CEO Issued Shareholder Letter To Provide Update; Milestone Includes Submission For Japan's Pharmaceutical and Medical Device Agency Approval Planned For End Of 2026; Driving To Enroll Confirmatory CardiAMP HF II Trial In US
BioCardia Inc BCDA
$0.97
▲ +2.09%
(+$0.02)
Open
$0.99
Prev Close
$0.95
Day Range
$0.92 – $1.03
52W Range
$0.78 – $2.45
Market Cap
$14.40M
Beta
0.50
EPS (TTM)
$-0.80
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1996-11-13 |
| Shares Out. | 14,880,000 |
| Website | biocardia.com/ ↗ |
| Phone | 13026587581 |
BioCardia Inc is a publicly traded company under the ticker symbol BCDA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-06-01)
📰 Latest News for BCDA
What's Going On With BioCardia Stock Tuesday?
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target
The trading volume of these stocks is deviating from the norm in today's session.
BioCardia Sells 3,509,604 Shares At Average Price Of $1.279 On June 5; No Warrants Issued In Capital Raise